Avicanna
Advantage
Advanced Natural
Cannabinoid Solutions
A Leader in Biopharmaceutical Advancements with Natural Cannabinoids
Avicanna is a Canadian vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global market place.
Advanced R&D, pre-clinical and clinical platform
- Cannabinoid R&D expertise – Team of 10+ scientists operating with Canadian Cannabis Research Licenses
- World-Class collaborations – with leading Canadian academic and clinical institutions
- 3 years of IP development – Proprietary methodologies in breeding, cultivation, extraction, formulation & clinical development, and analytical testing
Diversified and high margin income streams
- Comprehensive commercial portfolio – across consumer retail, medical cannabis and pharmaceutical market segments
- International footprint – multinational operations and commercial sales across US, Canada, LATAM and Europe
- Diversified revenue streams – seeds, API, formulations, finished products and licensing of IP
Low-cost vertical integration
- 2 Colombian subsidiaries – cultivation footprint of 480,000 sq feet and industrial extraction capacity
- Low cost, Organic and sustainable cultivation – ranked highest amongst global cannabis companies in the SAM Corporate Sustainability Assessment issued by S&P Global
Consumer Retail Products
Medical Products
Pharmaceutical Pipeline
Active Pharmaceutical Ingredients
Genetics and Seeds
